This communication describes the screening and diagnostic tools that can be used to identify obstructive sleep apnoea (OSA). It highlights the need to screen for OSA in all persons with metabolic syndrome and uses the term 'somnometabolic syndrome' to emphasise this. Somnometabolic syndrome can be easily screened at the primary care level, and should be an integral part of diabetes care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.47391/JPMA.22-102 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!